Posted by wallstreetrookie > 2022-09-18 18:18 | Report Abuse

Don't miss out

Posted by Gaussian > 2022-09-24 09:30 | Report Abuse

Omg. People who go there to seek eye issues will be asked to get operated. Lol

Posted by gohkimhock > 2022-09-24 11:19 | Report Abuse

所謂醫者父母心, 但是這個不是..

Posted by wallstreetrookie > 2022-09-24 11:49 | Report Abuse

Gaussian's comment
Stock: [HIBISCS]: HIBISCUS PETROLEUM BHD

2022-03-11 07:51 | Report Abuse

Buy more if drop

Stock

Posted by wallstreetrookie > 2022-09-24 11:50 | Report Abuse

Gaussian, you told people to buy Hibiscus at the top?

Posted by wallstreetrookie > 2022-09-24 11:50 | Report Abuse

Buy more Optimax

Posted by bojed > 2022-09-24 11:58 | Report Abuse

https://www.theedgemarkets.com/article/optimax-gets-sc-approval-main-market-transfer

It's a matter of time only.

Posted by Gaussian > 2022-09-24 19:56 | Report Abuse

Sell on news next week. Lol

Posted by Gaussian > 2022-09-24 19:56 | Report Abuse

Buy more when Optimax drop next week. Lol

Posted by Noni > 2022-09-25 07:43 | Report Abuse

Competitions coming in, should see some changes

Posted by bojed > 2022-09-27 15:37 | Report Abuse

YEEEEEEEEEEEHAAAAAAAAAAAAAA!!!!!!!!!

Posted by Godafall > 2022-09-27 16:37 | Report Abuse

so senyap here. where everybody go?

Posted by bojed > 2022-10-03 19:47 | Report Abuse

Despite being red, Optimax actually closed just above the ema20 support. Let's go!

Posted by bojed > 2022-10-14 08:43 | Report Abuse

Pullback at ema50? Hopefully.

Posted by bojed > 2022-10-14 16:16 | Report Abuse

go go go!

Posted by bojed > 2022-10-21 14:24 | Report Abuse

Relax.

Posted by bojed > 2022-10-26 10:16 | Report Abuse

NO MORE RELAXING! GO GO GO!!!

Posted by chiahs > 2022-10-27 13:55 | Report Abuse

27Oct2022, Bursa Securities has approved the Transfer FROM THE ACE MARKET TO THE MAIN MARKE
https://www.klsescreener.com/v2/announcements/view/3628057

Posted by chiahs > 2022-10-27 13:55 | Report Abuse

27Oct2022, Bursa Securities has approved the Transfer FROM THE ACE MARKET TO THE MAIN MARKE
https://www.klsescreener.com/v2/announcements/view/3628057

Posted by bojed > 2022-10-27 16:54 | Report Abuse

INI KALILAH!

Posted by bojed > 2022-11-02 13:05 | Report Abuse

TOMORROW!

Posted by wallstreetrookie > 2022-11-02 16:50 | Report Abuse

Optimax is one of the most successful IPO on the healthcare ACE market. More successful for Cengild

Posted by wallstreetrookie > 2022-11-02 16:50 | Report Abuse

I have been holding since IPO

Posted by wallstreetrookie > 2022-11-02 16:50 | Report Abuse

Optimax is the next Greatech. You just watch

Posted by Godafall > 2022-11-02 16:56 | Report Abuse

Let's see what will happen tmr

Posted by wallstreetrookie > 2022-11-02 18:01 | Report Abuse

Really love the management team of Optimax. This company gives me the vibes like Harnlen. The growth potential of Optimax is endless. A lot of investors are putting money in healthcare; Eye-specialist services will keep expanding at an estimated CAGR of 6% as Malaysia aging population grows and increased demand for cataract treatments.

I am super bullish

Posted by wallstreetrookie > 2022-11-02 18:05 | Report Abuse

Trust me, take some money and put it into Optimax-WA and hold until 2026. You might be able to retire early

Posted by bojed > 2022-11-04 18:06 | Report Abuse

KALI INILAH!

Posted by Akifuyu > 2022-11-07 16:30 | Report Abuse

need to wait another 1 month

Posted by Serenevalley > 2022-11-07 20:06 | Report Abuse

One month also cannot

Posted by bojed > 2022-11-08 10:05 | Report Abuse

Dah lama sangat rehat ni... Come on!

Posted by Serenevalley > 2022-11-08 19:15 | Report Abuse

No lah

Posted by Akifuyu > 2022-11-10 14:53 | Report Abuse

support level at 0.70?

Posted by wallstreetrookie > 2022-11-10 15:06 | Report Abuse

Sure, Optimax is a long term play

Posted by Lightofheaven > 2022-12-05 11:31 | Report Abuse

Optimax bought
Optimax-wa also bought

Keep for long term and grannie will thanks me.

Drinking my starbuck first

Posted by JTleong > 2022-12-08 00:36 | Report Abuse

Optimax is all about the patience. Lets go

Posted by Lightofheaven > 2022-12-13 08:21 | Report Abuse

Optimax continue to fly fly fly..
strong company and investor is full of confident

Posted by Lightofheaven > 2022-12-15 16:58 | Report Abuse

lai liao..kick lai liao..lai lai lai..
talk east talk west talk kok.

Posted by Lightofheaven > 2022-12-15 16:58 | Report Abuse

Optimax is the boss

Posted by nasgee > 2022-12-21 11:24 | Report Abuse

afternoon flyyy fasetrrrr

Posted by Lightofheaven > 2022-12-21 12:21 | Report Abuse

hold tight2 for sure
Optimax gogogo

Posted by wallstreetrookieNEW > 2022-12-22 15:43 | Report Abuse

Sold Optimax. Time to take profits and cash out

Posted by Lightofheaven > 2023-01-13 09:41 | Report Abuse

i see lots of potential in this optimax..invest and keep for promising profit return.

Posted by kimpau > 2023-02-03 10:27 | Report Abuse

stay tuned!!! more n more fantastic good news ahead!!! golden black horse which the price will be RM1.18 within few months!!!

Posted by kimpau > 2023-02-03 10:28 | Report Abuse

the warrant of Optimax will double triple your $$$ !!!!

Posted by ming > 2023-02-27 00:27 | Report Abuse

198. Regarding the issue of overcrowding in public health facilities, several measures will be undertaken.

The nation’s health capacity will be optimised by outsourcing patients from overcrowded hospitals to other hospitals, including university hospitals, military hospitals and private hospitals.

Posted by Peace99 > 2023-02-28 15:55 | Report Abuse

Why suddenly down so much?

Posted by Peace99 > 2023-02-28 16:27 | Report Abuse

Young ppl go for Lasik, seniors go for cataract--replacement of lens by artificial lens. Johor clinic will attract Singaporeans, when they come over for happy weekends! So, why down so much? I top up some already.

Posted by kimpau > 2023-03-01 12:19 | Report Abuse

Optimax Holdings - FY22: Earnings and DPS In-line
Date:
2023-03-01
Firm:
MAYBANK
Stock:
OPTIMAX
Price Target:
0.86
Price Call:
BUY
Last Price:
0.745
Upside/Downside:
+0.115 (15.44%)
Maintain BUY With Higher TP of MYR0.86
Optimax’s FY22 core net profit was within our expectations, coming in at MYR14.7m, making up 100%/97% of our/consensus FY22E earnings forecast. We adjust FY23E/FY24E by +2%/-11%, factoring for minor housekeeping and leaving room for potential delays in the construction of the Kempas hospital, which we now assume to commence operations by FY25 (prev. 2HFY24). We also introduce FY25E forecasts. Maintain BUY with a higher, DCF-based TP of MYR0.86 (prev. MYR0.84).

4Q22: Slight Margin Contraction as New Centres Open
4Q22 core net profit increased to MYR3.8m (+7% YoY, 4% QoQ) aided by maiden revenue contribution from newly opened eye specialist centres, bringing 4Q22 revenue to MYR28.4m (+6.8% YoY, -1.1% QoQ). We believe the new loss-making centres which opened in 2H22 were the cause of the EBITDA and PBT margin contractions, both YoY and QoQ. However, net profit margins remained level (+0.1 ppt YoY) or increased (+0.7ppts QoQ) as minority shareholder resident doctors shared in the losses of the new centres.

Steady FY22 Core Operations; DPS Expectations Met
We remain upbeat on Optimax’s core operations, with FY22 core net profit growing by 20% YoY to MYR14.7m, contributed by higher revenue of MYR108m (+22% YoY) which was driven by the re-opening of the economy, resilient demand for eye surgeries, and maiden revenue contribution from new centres. As expected, Optimax announced a second interim DPS of 1.2 sen, which will be paid out on 30 Mar 2023. This brings total DPS announced for FY22 to 2.4 sen (1.2 sen announced in 3Q22), which translates to total dividends of MYR13.0m and a dividend payout ratio of 88% of core net profit. We maintain our DPR assumptions of 80% for FY23E/FY24E/FY25E.

Expansion Plans Continue
In the 3Q22 results briefing, management shared that the Bahau ACC and Cheras satellite clinic were fully operational by end-3Q22, with 2 new satellite clinics slated to open in 4Q22. Management also shared intentions to open 7 new satellite clinics in FY23. Moving forward, we expect higher revenue contribution from consultations and treatment of other eye diseases, but minor margin contractions as new centres steadily mature.

Source: Maybank Research - 1 Mar 2023

Posted by kimpau > 2023-03-01 12:20 | Report Abuse

Summary
Optimax Holdings Bhd’s (OPTIMAX) 4Q22 core net profit improved 7.5% YoY to RM3.8m, bringing a 20.0% YoY increase on its FY22 core net profit to RM14.7m. The results came in within expectation, amounting to 102.1% of our full year forecast of RM14.4m. Meanwhile, an interim dividend of 1.2 sen per share, payable on 30th March 2023 was declared.
QoQ, core net profit showed an improvement of 4.1% to RM3.8m, despite a drop of 1.1% QoQ decline in its revenue to RM28.4m and this was mainly due to the lower minority interest of –RM0.2m registered for 4Q22 vs RM1.1m in 3Q22.
FY22 core net profit climbed 20.0% YoY, mainly attributed from (i) the increase in revenue arising from higher number of surgeries conducted amid economy reopening, (ii) effective marketing effort from ongoing promotions via online platforms, and (iii) better control over operating costs by leveraging on the experience gained from multiple lockdowns since March 2020.
Moving forward, OPTIMAX will continue to boost the capacity of its Ambulatory Care Centre (ACC) in regions other than central Malaysia by hiring more surgeons. Meanwhile, the group continued to seek strategic locations to set up more satellite clinics to support its growth, targeting 5 satellite clinics in FY23.
We expect its new ACC in Bahau, Negeri Sembilan and satellite clinic in Taman Sutera, Johor which were both established in FY22, would secure more patients and operate above break-even in the following 6-12 months, resulting in a higher margin for the group.
There is no material development pertaining to both MoU entered into with Selgate Healthcare Sdn. Bhd., as well as with Sena Resources Sdn. Bhd. and Kempas Eye Specialist Hospital Sdn. Bhd.
Valuation & Recommendation
Although the reported earnings came in within our expectations, we upgrade our FY23f earnings forecast by 6.9% to RM15.5m, taking into account the higher expectation on number of surgeries to be conducted amid economic reopening. Meanwhile, the core net profit forecast for FY24f is introduced at RM17.6m.
We maintained our BUY recommendation on OPTIMAX with a revised target price of RM1.15 (from RM1.07). The target price is based on the assigned target PER of 40.0x to our revised FY23f EPS of 2.9 sen.
Risks to our recommendation include the possible resurgence of Covid-19 infections which may result in postponement of surgeries. Besides, the inflationary pressure amid rising food and energy prices remains as threat to local economy.
Source: Mplus Research - 1 Mar 2023